Transparency Market Research
Cell and Gene Therapy Manufacturing Market to Achieve a Valuation of USD 8.8 billion by 2031| Analysis by Transparency Market Research
09 nov. 2023 08h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing market is projected to flourish at a CAGR of...
NorthX_tworow_color_RGB.jpg
NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support
01 nov. 2023 04h00 HE | NorthX Biologics Matfors AB
NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support
NorthX_tworow_color_RGB.jpg
NorthX Biologics AB Announces Inauguration of Innovation Hub at Matfors Facility
28 sept. 2023 03h00 HE | NorthX Biologics Matfors AB
NorthX Biologics AB is proud to announce the official inauguration of its state-of-the-art Innovation Hub at the Matfors facility.
TIP_link_300x300.jpg
Cell and Gene Therapy Manufacturing Services Market worth $26.72 Billion, Globally, by 2030 – Comprehensive Study by The Insight Partners
27 sept. 2023 10h12 HE | The Insight Partners
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and commercial approval. Establishing...
Transparency Market Research
Cell and Gene Therapy Manufacturing Quality Control (QC) Market to Reach USD 2.8 billion by 2031, Expanding at a CAGR of 24.6 % Says, Transparency Market Research
28 août 2023 04h01 HE | Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing quality control (QC) market is projected to...
NorthX_tworow_color_RGB.jpg
NorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unit
23 août 2023 04h00 HE | NorthX Biologics Matfors AB
MATFORS, Sweden, Aug. 23, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics AB, (‘NorthX’), a leading Nordic development and manufacturing organisation with a focus on advanced biologics, CGT (cell and gene...
logo.png
Cell and Gene Therapy Market to Worth Around USD 1,17,100 Million by 2032
10 août 2023 11h50 HE | Precedence Research
Ottawa, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The global cell and gene therapy market revenue is estimated to surpass around USD 45,700 million by 2028, a study published by Towards Healthcare a sister...
NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542 (1).png
National Marrow Donor Program® (NMDP)/Be The Match® Names Christina Melief, Ph.D., Senior Scientific Advisor
25 juil. 2023 17h01 HE | Be The Match
Dr. Melief will work to simplify and accelerate the acquisition of cord blood units for transplant and cell and gene therapies through expanded access for transplant centers, cord blood banks, and...
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
05 juil. 2023 04h00 HE | AKAMPION
- Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off PRESS RELEASE. Cologne, Germany — July 05, 2023 - Cellbox Solutions GmbH, a leading provider of warm...
NorthX_tworow_color_RGB.jpg
NorthX Biologics, ledande nordisk biofarmaceutisk tillverkare och innovationshubb, förvärvar avancerad tillverkningsenhet för kliniska prövningar från Valneva
03 juil. 2023 08h00 HE | NorthX Biologics Matfors AB
MATFORS, Sverige, July 03, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics ('NorthX'), en nordisk innovationshubb och ledande inom processutveckling och tillverkning av avancerade biologiska läkemedel,...